The tampering went undetected for months. Resident 8's 30-milliliter morphine sulfate bottle, filled by the pharmacy on May 28, sat on medication carts through dozens of shift changes before a nurse noticed 3.5 milliliters had vanished.
LPN 115 discovered the discrepancy on November 14 during a routine controlled medication count with the night shift nurse. The bottle hadn't been documented as used since the pharmacy filled it nearly six months earlier. When the director of nursing turned the punctured bottle upside down, liquid medication dripped out.
Nobody had caught it the night before. The previous shift change between day nurse LPN 300 and night nurse LPN 166 on November 13 showed no problems in their controlled substance count.
The director immediately launched a facility-wide audit of all controlled medications. That's when staff found the second violation. Resident 50's liquid morphine sulfate bottle also showed a puncture hole in its seal.
But this tampering was more sophisticated. Someone had removed morphine and replaced it with another solution to mask the theft.
The director contacted the facility's contracted pharmacist on November 14, who notified the Ohio Board of Pharmacy. State investigators arrived November 19 and confirmed both bottles had been tampered with.
The investigation revealed a breakdown in the facility's controlled substance monitoring. Nurses failed to properly reconcile medications stored in the 400 hall medication cart when keys changed hands between November 13 and 14.
Facility policy from December 2012 required physical inventory of all Schedule II medications at every shift change. Two licensed nurses were supposed to conduct counts whenever keys transferred and document everything on controlled substances accountability records.
That didn't happen.
The policy stated that controlled medications required "special handling, storage, and record keeping" under federal and state laws. The director of nursing and consultant pharmacist were responsible for monitoring compliance.
The morphine bottles sat in plain sight on top of the medication cart during the November 14 shift change, making the tampering obvious once someone looked closely. But the puncture in Resident 8's bottle was small enough that it took months to discover.
The facility couldn't determine when the tampering occurred. Resident 8's bottle had been filled in late May, meaning the medication sat vulnerable for nearly six months. The timing of Resident 50's bottle tampering remained unclear.
State pharmacy board investigators used their expertise to distinguish between manufacturing defects and intentional tampering. They concluded both bottles showed clear evidence of deliberate puncturing.
The 3.5 milliliters missing from Resident 8's bottle represented a significant amount of the powerful opioid. Morphine sulfate is typically administered in small doses, meaning the missing medication could have provided multiple doses for someone seeking to divert the drug.
The replacement solution in Resident 50's bottle showed premeditation. Someone took time to substitute the morphine with another liquid to avoid detection during routine counts.
The director of nursing contacted his clinical legal team immediately after learning of the discrepancy. The whole-house audit he ordered checked every controlled substance in the facility, but found no other evidence of tampering.
The investigation highlighted gaps in the facility's controlled substance security. Despite written policies requiring counts at every shift change, the system failed to detect tampering that may have continued for months.
Morphine sulfate is a Schedule II controlled substance under Drug Enforcement Administration classification, requiring the highest level of security and monitoring in healthcare facilities. The medication provides powerful pain relief for residents but also creates diversion risks when security breaks down.
The Ohio Board of Pharmacy's involvement elevated the investigation beyond internal facility review. State investigators brought specialized knowledge about medication tampering patterns and detection methods that facility staff lacked.
The timing of the discovery during a Friday shift change meant the investigation stretched across a weekend, with state officials not arriving until the following Tuesday. The bottles remained as evidence throughout that period.
Both residents affected by the tampering continued receiving their prescribed pain medications from new, untampered bottles. The investigation focused on the missing medication rather than any impact on patient care.
The facility reported the incident under complaint number 2672468, triggering the federal inspection that documented the violations. State and federal oversight now monitors the facility's controlled substance procedures.
The case remains under investigation by the Ohio Board of Pharmacy, which has authority to pursue criminal charges for medication diversion if evidence supports prosecution.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Belpre Landing Nursing and Rehabilitation from 2025-11-24 including all violations, facility responses, and corrective action plans.
Additional Resources
- View all inspection reports for Belpre Landing Nursing and Rehabilitation
- Browse all OH nursing home inspections